Inventor · disambiguated record
Cinzia Bizzarri
Also filed as: BIZZARRI CINZIA
18 granted patents·3 pending applications·55 citations·filing 1999–2012
89Inventor score
Files withALLEGRETTI MARCELLO6DOMPE PHA R MA SPA RES & MFG5DOMPE SPA5MORICONI ALESSIO2DOMPE PHAR R MA S P A1
Top patents by PatentIndex Score
21 records- 0178US7868046B2(2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing themDOMPE PHA R MA SPA RES & MFG·Filed 2009·Granted Jan 11, 2011·3 cites·4 claims
- 0277US7652169B2(2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing themDOMPE PHA R MA SPA RES & MFG·Filed 2007·Granted Jan 26, 2010·3 cites·8 claims
- 0374US6069172A(R)-2-(3-benzoylphenyl) propionic acid salts and pharmaceutical preparations containing themDOMPE SPA·Filed 1999·Granted May 30, 2000·44 cites·24 claims
- 0465US8063242B22-aryl-propionic acids and pharmaceutical compositions containing themALLEGRETTI MARCELLO·Filed 2002·Granted Nov 22, 2011·3 cites·10 claims
- 0564US7026510B2Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing themDOMPE SPA·Filed 2002·Granted Apr 11, 2006·2 cites·17 claims
- 0659US9328057B2Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseasesALLEGRETTI MARCELLO·Filed 2008·Granted May 3, 2016·0 cites·8 claims
- 0756US2008045522A1Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cellsDOMPE PHA R MA SPA RES & MFG·Filed 2007·Application pending·0 cites
- 0854US9493402B2Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cellsDOMPÉ S P A·Filed 2012·Granted Nov 15, 2016·0 cites·4 claims
- 0954US7776909B22-aryl-acetic acids, their derivatives and pharmaceutical compositions containing themDOMPE PHA R MA SPA RES & MFG·Filed 2004·Granted Aug 17, 2010·0 cites·10 claims
- 1051US6881755B2N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing themDOMPE SPA·Filed 2003·Granted Apr 19, 2005·0 cites·1 claims
- 1150US2006247297A1Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseasesALLEGRETTI MARCELLO·Filed 2003·Application pending·0 cites
- 1249US8648110B22-aryl-acetic acids, their derivatives and pharmaceutical compositions containing themMORICONI ALESSIO·Filed 2011·Granted Feb 11, 2014·0 cites·4 claims
- 1348US8871784B22-aryl-acetic acids, their derivatives and pharmaceutical compositions containing themMORICONI ALESSIO·Filed 2010·Granted Oct 28, 2014·0 cites·4 claims
- 1445US7737139B2Sulfonic acids, their derivatives and pharmaceutical compositions containing themDOMPE PHA R MA SPA RES & MFG·Filed 2004·Granted Jun 15, 2010·0 cites·12 claims
- 1545US7674806B2Amidines and derivatives thereof and pharmaceutical compositions containing themALLEGRETTI MARCELLO·Filed 2004·Granted Mar 9, 2010·0 cites·7 claims
- 1644US8288368B2Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cellsALLEGRETTI MARCELLO·Filed 2002·Granted Oct 16, 2012·0 cites·5 claims
- 1738US2009131441A1Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing ThemDOMPE PHAR R MA S P A·Filed 2006·Application pending·0 cites
- 1835US7939521B22-arylpropionic acid derivatives and pharmaceutical compositions containing themDOMPEPHA R MA S P A·Filed 2005·Granted May 10, 2011·0 cites·7 claims
- 1935US7705050B2Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophilsALLEGRETTI MARCELLO·Filed 2001·Granted Apr 27, 2010·0 cites·16 claims
- 2034US7217707B2Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activationDOMPE SPA·Filed 2001·Granted May 15, 2007·0 cites·14 claims
- 2129US6887903B1N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing themDOMPE SPA·Filed 1999·Granted May 3, 2005·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Cinzia Bizzarri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →